Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 42 out of 100. Down syndrome and Alzheimer's

Topic: Risk, prevention and care in population studies

Abstract Purpose of Review Adults with intellectual disability (ID) experience a disproportionate burden of sleep disorders with major impacts on physical, neuropsychiatric and behavioural health, yet evidence to guide practice has lagged behind the general population. This review updates our 2024 narrative synthesis, focusing on clinically actionable advances in sleep health for adults with ID. Recent Findings Recent observational data in adults with Down syndrome indicate that obstructive sleep apnoea is associated with adverse cardiometabolic, mortality and Alzheimer disease outcomes. Positive airway pressure can be feasible with individualised support, while retrospective studies of surgical treatment suggest possible benefits in selected patients, although residual OSA and confounding by treatment selection remain important considerations. Emerging diagnostic technologies, including home-based acoustic sensors, wearables, cardiorespiratory algorithms and three-dimensional facial biomarkers, represent promising developments that require further evaluation against established diagnostic pathways. Meta-analytic and cohort studies describe aetiology-related sleep phenotypes and persistent sleep and circadian disruption in autistic adults; a small uncontrolled case series provides preliminary evidence that daridorexant may be tolerated and associated with improved sleep in selected adults with intellectual disability. Summary Despite recent advances, major inequalities persist, highlighting the need for accessible diagnostics, population‑specific instruments and adult‑focused guidelines embedding sleep management within lifelong care for people with ID.

Key findings

Why it matters

This review reports that in adults with Down syndrome, obstructive sleep apnoea is associated with adverse Alzheimer disease outcomes, and that treatments such as positive airway pressure and surgery have been studied with limitations. It is a review of observational and retrospective data and does not establish that treating sleep apnoea prevents or cures Alzheimer's disease.

Study details

How this study scored 42/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 2 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 42 of 100.42 of 100 points earned58 not earned

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Current Treatment Options in Neurology)
Journal's citation record 1 / 4 Current Treatment Options in Neurology: journal h-index 77 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author David John O'Regan: h-index 34 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multi-centre collaboration 2 / 3 OpenAlex lists 5 institution(s) in 2 countries
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 42 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Sirinimnualkul, N., Perera, B., & O'Regan, D. J. (2026). Sleep Health in Adults with Intellectual Disability: Recent Advances and Persistent Evidence Gaps. Current Treatment Options in Neurology. https://doi.org/10.1007/s11940-026-00892-8

Vancouver

Sirinimnualkul N, Perera B, O'Regan DJ. Sleep Health in Adults with Intellectual Disability: Recent Advances and Persistent Evidence Gaps. Current Treatment Options in Neurology. 2026. doi:10.1007/s11940-026-00892-8.

BibTeX

@article{sirinimnualkul2026-0b24ddbe,
  author  = {Sirinimnualkul, Naphat and Perera, Bhathika and O'Regan, David John},
  title   = {{Sleep Health in Adults with Intellectual Disability: Recent Advances and Persistent Evidence Gaps}},
  journal = {Current Treatment Options in Neurology},
  year    = {2026},
  doi     = {10.1007/s11940-026-00892-8},
  url     = {https://doi.org/10.1007/s11940-026-00892-8}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Down syndrome and Alzheimer's

Also tagged “down”

527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.

Similar studies

More on Down syndrome and Alzheimer's

See all studies in Down syndrome and Alzheimer's →